ECM
XBIT icon

Element Capital Management’s XBiotech XBIT Stock Holding History

Element Capital Management’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-30,184
Closed -$96K – 913
2018
Q3 		$96K Sell
30,184
-43,342
-59% -$169K ﹤0.01% 853
2018
Q2 		$329K Buy
+73,526
New +$332K 0.01% 516

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Element Capital Management's XBIT Position: Q4 2018 in Review

Element Capital Management sold out of XBiotech (XBIT) in Q4 2018, closing a stake of 30,184 shares — an estimated $96K sold.

Element Capital Management first reported a position in XBIT in Q2 2018 and held it in 2 quarters. The position peaked at $329K in Q2 2018. 25 funds tracked by Wall St. Rank hold XBIT as of Q4 2018.

  • Element Capital Management reported no remaining XBiotech position as of Q4 2018 after selling out during the quarter.
  • Element Capital Management sold 30,184 XBiotech shares in Q4 2018, an estimated $96K.
  • Element Capital Management first reported a position in XBiotech in Q2 2018 and held it in 2 quarters.
  • Element Capital Management's XBiotech position peaked at $329K in Q2 2018.
  • 25 funds tracked by Wall St. Rank held XBiotech as of Q4 2018.

Based on Element Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.